Trials

Home Trials

Atopic Dermatitis Study - Ages 12 and Up (Oral)

Now Enrolling Patients Age 12 and Older

Do you or your child struggle with moderate to severe atopic dermatitis (eczema)?

We are currently enrolling patients ages 12 and above in a Phase 2 clinical research study evaluating an investigational oral medication for atopic dermatitis.

This study involves a promising new technology designed to target inflammation in a novel way. Because this is a Phase 2 study, the medication has already undergone earlier safety testing and has shown encouraging results.

Why Consider This Study?

✔ Investigational oral medication (pill) — not an injection
✔ Designed using innovative, targeted technology
✔ Phase 2 trial with prior safety experience
✔ Study-related medication and care provided at no cost
✔ Compensation provided for time and participation
✔ Travel reimbursement available for those coming from a distance

Many patients in this age group currently rely on injectable medications. This study offers the opportunity to participate in research evaluating a potential oral alternative.

Who May Qualify?

You may be eligible if you:

  • Are 12 years of age or older
  • Have a diagnosis of moderate to severe atopic dermatitis
  • Have had symptoms for at least 1 year
  • Have active eczema despite prior treatment
  • Are willing to attend scheduled study visits

Who May Not Qualify?

You may not be eligible if you:

  • Have certain uncontrolled medical conditions
  • Have active or chronic infections
  • Are currently participating in another clinical trial
  • Are pregnant or breastfeeding
  • Have recently used certain biologic or systemic medications (study team will review specifics)

A full screening evaluation will determine eligibility.

What to Expect

Participants will:

  • Receive study-related care and monitoring
  • Undergo physical exams and routine laboratory testing
  • Be closely followed by experienced research professionals
  • Help advance potential new treatments for eczema
Interested in Learning More?

Participation is completely voluntary.
If you or your child may qualify and would like more information, please contact our study team.